查詢結果分析
來源資料
相關文獻
- Marked Decrease of Cyclosporin Absorption Caused by Coadministration of Cordyceps Sinensis in Rats
- Effects of Coadministrations of Unripe Fruits and Ripe Reels of Citrus Aurantium on Cyclosporine Pharmacokinetics in Rats
- 甘草酸對芍藥苷藥物動力學之影響
- 中藥對CYCLOSPORIN之藥品動力學影響
- 加護病房內藥物交互作用之考量
- St. John's Wort-Cyclosporin Interaction in Rats and Pigs
- 中西藥併用之安全性探索(整合型計畫)--分項計畫二:以體內及體外試驗模式探索大黃及何首烏對phenytoin動力學之影響
- 中藥補陽還五湯作用於阿斯匹靈在大白鼠體內藥物動力學與藥效學的交互作用
- Correlation between Cytochrome P450 2D6 Genotype and Methadone Concentration-to-dose Ratio
- Phenytoin血中濃度過高之討論
頁籤選單縮合
題名 | Marked Decrease of Cyclosporin Absorption Caused by Coadministration of Cordyceps Sinensis in Rats=冬蟲夏草顯著降低環孢靈於鼠體內之吸收 |
---|---|
作者 | 江秀梅; 侯鈺琪; 蔡尚元; 楊詩盈; 李珮端; 徐素蘭; 溫國慶; | 書刊名 | 藥物食品分析 |
卷期 | 13:3 2005.09[民94.09] |
頁次 | 頁239-243+291 |
分類號 | 414.51 |
關鍵詞 | 冬蟲夏草; 環孢靈; 藥物動力學; 交互作用; Cordyceps sinensis; Cyclosporin; Pharmacokinetics; Drug interaction; |
語文 | 英文(English) |
中文摘要 | 冬蟲夏草在台灣及中國大陸為常用之補益藥,環孢靈於臨床上則為重要之免疫抑制劑,但其治療指數很小,因此本研究探討併服冬蟲夏草於鼠體內對環孢靈動力學之影響。本研究分別以靜脈注射(0.8 mg/kg)或口服(2.5mg/kg)給予環孢靈,以交叉設計給藥,實驗組口服給予冬蟲夏草(2.0g/kg),對照組則給予等體積蒸餾水,以心臟採血方式於特定時間點採取血液樣本。血液樣本以偏極螢光免疫分析方法(FPIA)分析環孢靈血中濃度,並以非室體模式計算口服及靜脈注射環孢靈之動力學參數,以pairedStudent’s t-test比較組間差異。結果發現同時服用冬蟲夏草時,口服環孢靈之Cmax與AUC0-540顯著降低了85.5%與83.2%;此外,於口服環孢靈前一小時先給予冬蟲夏草,其Cmax與AUC0-540亦顯著降低了85.9%與84.4%,;然而環孢靈以靜脈注射給予時,其動力學參數並不受到併服冬蟲夏草之影響,顯示二者之交互作用應發生於吸收過程。以上結果顯示併服冬蟲夏草顯著降低環孢靈之生可用率,因此使用環孢靈之病人應建議其避免同期使用冬蟲夏草,以確保藥效及安全性。 |
英文摘要 | Cordyceps (Cordyceps sinensis SACCARDO.) is a popular traditional tonic used in Taiwan and mainland China. Cyclosporin is an important immunosuppressant with narrow therapeutic index. This study investigated the effect of coadministration of cordyceps on cyclosporin pharmacokinetics in rats. Cyclosporin was intravenously (0.8 mg/kg) and orally (2.5 mg/kg) administered with and without cordyceps (2.0 g/kg), respectively, in crossover designs. Blood samples were collected by cardiopuncture and quantitated by a specific monoclonal fluorescence polarization immunoassay. Pharmacokinetic parameters of cyclosporin were calculated using noncompartment model. Paired Student's t-test was used for statistical comparison. Our results indicated that oral coadministration of cordyceps significantly decreased the Cmax and AUC0-540 of cyclosporin by 85.5% and 83.2%, respectively. In addition, when rats were given cordyceps 1 hr before cyclosporin dosing, the Cmax and AUC0-540 of cyclosporin were significantly decreased by 85.9% and 84.4%, respectively. By contrast, when cyclosporin was given as an intravenous bolus, the disposition of cyclosporin was not altered by cordyceps, indicating that the interaction between oral cyclosporin and cordyceps occurred during the absorption phase. In conclusion, cordyceps markedly decreased the oral bioavailability of cyclosporin. Patients treated with cyclosporin are suggested to avoid the concurrent use of cordyceps for efficacy and safety. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。